Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,551 | 1,837 | 5,397 | 11,446 | 13,254 |
| Receivables | 1,776 | 984 | 647 | 951 | 926 |
| TOTAL | $7,031 | $3,891 | $6,515 | $13,681 | $15,852 |
| Non-Current Assets | |||||
| PPE Net | 173 | 193 | 215 | 236 | 231 |
| Investments And Advances | 0 | 0 | 8 | 59 | 68 |
| Intangibles | 2,044 | 2,044 | 2,044 | 2,044 | 2,044 |
| Other Non-Current Assets | 43,000 | 40,826 | 6,326 | 6,259 | 2,731 |
| TOTAL | $45,217 | $43,063 | $8,593 | $8,598 | $5,074 |
| Total Assets | $52,248 | $46,954 | $15,108 | $22,279 | $20,926 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,107 | 4,425 | 3,211 | 3,370 | 1,150 |
| Accrued Expenses | 5,019 | 2,109 | 2,012 | 3,626 | 3,230 |
| Other current liabilities | N/A | 450 | 8 | 363 | 2,648 |
| TOTAL | $9,626 | $7,165 | $5,406 | $7,654 | $7,467 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 349 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 38,810 | 35,673 | 2,072 | 2,518 | 4,640 |
| TOTAL | $39,060 | $35,923 | $2,322 | $2,518 | $4,646 |
| Total Liabilities | $48,686 | $43,088 | $7,728 | $10,172 | $12,113 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14 | 14 | 14 | 14 | 8 |
| Common Shares | 27 | 27 | 26 | 26 | 15 |
| Retained earnings | -180,820 | -175,229 | -170,713 | -165,297 | -160,799 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 1 |
| TOTAL | $3,562 | $3,866 | $7,380 | $12,107 | $8,813 |
| Total Liabilities And Equity | $52,248 | $46,954 | $15,108 | $22,279 | $20,926 |